Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 3 of the 17 sources its claims cite were checked for support.
Abstract
Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized ≈16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
Overview
CoChat Summary
TL;DR
This study developed a method to isolate microgram quantities of drusen and analyzed their proteome by LC MS/MS, identifying 129 proteins from normal and AMD donor eyes. It reports oxidative protein modifications, especially carboxyethyl pyrrole adducts, that are more abundant in AMD Bruch’s membrane, supporting a role for oxidative injury in AMD pathogenesis.
Key findings
- LC MS/MS of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins: 107 from normal donors and 62 from AMD donors. About 38% (41/107) of normal-donor proteins were also found in AMD donors, and 65% (42/62) of AMD-donor proteins were found in normal donors; 21 of 62 AMD proteins (≈33%) were not observed in normal donor drusen.
- TIMP3, clusterin, vitronectin, and serum albumin were the most common proteins in normal donor drusen, detectable in up to 80% of tissues from the 18 normal donors and 60% of drusen preparations from the five AMD donors. Crystallin was detected more frequently in AMD donor drusen.
- Immunocytochemistry localized ≈16% (21/129) of identified proteins in drusen.
- Oxidative modifications were observed, including apparent crosslinked species of TIMP3 and vitronectin and carboxyethyl pyrrole (CEP) protein adducts. By Western analysis, CEP immunoreactivity was present in 9 of 11 AMD samples versus 2 of 11 age-matched controls (Fischer’s test, P = 0.004 single-sided); carboxymethyl lysine was also detected in drusen.
Methods
- Human donor eyes from 29 normal and 16 AMD donors, ages 56–98 years, were used. Drusen isolation and protein identification used 23 eyes (18 normal, five AMD); Western analyses used 22 eyes (11 normal, 11 AMD). Eyes were enucleated 1.5–7 h after death and frozen.
- Drusen were manually isolated from Bruch’s membrane, proteins were extracted, trypsin-digested, and analyzed by liquid chromatography tandem MS (LC MS/MS) with database searching. Immunocytochemistry and Western analysis were used to confirm drusen localization and detect oxidative modifications.
- For CEP Western analysis, Bruch’s membrane/RPE/choroid from AMD and age- and gender-matched normal donors was subjected to SDS/PAGE (≈20 µg protein per lane) and probed with anti-CEP antibodies.
Limitations
- The paper states that mass spectrometric analyses did not measure protein abundance; the number of proteins identified per drusen preparation varied from 0 to 39 and averaged 19. It also notes that some identified proteins may be soluble contaminants or, as with annexin II, localized to RPE tissue adhering to drusen, and that additional AMD donors are required to establish the significance of the crystallin observation.
- The paper states that whether any drusen protein is uniquely associated with AMD remains to be determined.
- Evident from the text: the AMD proteomic group was small (five donors), many isolated drusen were from far peripheral locations, and immunocytochemical confirmation covered only ≈16% of identified proteins.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 8 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Among the nine identified immunopositive proteins were albumin and 𝛂 1-antitrypsin, both of which were detected in drusen by LC MS ∕ MS (Table 3) and immunocytochemistry (14).”
What the sources say
- Disputedcites [14] matched to “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease” (2000) sourceExperimental — accuracy not yet measured
Our copy of Mullins et al. (2000) directly contradicts the attributed point: in the Immunohistochemistry section it states that 'Antibodies directed against human serum albumin and haptoglobin bound strongly to the choroidal stroma, but not to hard or soft drusen,' and Table 1 scores Albumin as negative for drusen (figure legend for panel J repeats that labeling was not generally observed with albumin antibodies). Alpha-1-antitrypsin is likewise not presented as an identified drusen component — the same section reports 'Weak and/or inconsistent drusen labeling of antibodies directed against the protease inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin,' and Table 1 lists it as negative with only rare variable reactions. The proteins the paper does identify in all drusen phenotypes are amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X and complement C5/C5b-9 (Abstract; Immunohistochemistry), and the study contains no carboxyethylpyrrole/CEP-adduct work and no LC-MS/MS data. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The multiple, higher mass electrophoretic components containing these proteins suggest the presence of covalent crosslinks, protein modifications that can be caused by reactive lipid and carbohydrate oxidation products (22, 23).”
What the sources say
- Partly supportedcites [22] Friguet, B., Stadtman, E. R. & Szweda, L. I. (1994) J. Biol. Chem. 269, 21639-21643. sourceExperimental — accuracy not yet measured
Friguet et al. (1994) directly support the lipid-oxidation half of what the paired citation is offered for: the Cross-linking of Glu-6-PDH by HNE section (Fig. 1) shows progressive appearance of higher-mass multimeric (dimeric, tetrameric) protein on SDS-gel filtration and SDS-gel electrophoresis after exposure to the lipid peroxidation product HNE, i.e. covalent cross-links, and the Discussion/Abstract state this explicitly. Our copy contains no passage attributing cross-linking to carbohydrate oxidation products (searched: carbohydrate/glycation cross-linking — only lipid peroxidation products HNE and malondialdehyde are discussed), so that half of the claim is not supported by this source; the cross-links shown are also formed in vitro on a heterologous bacterial model enzyme at 5 mM HNE, with the Discussion conceding basal in vivo HNE concentrations are ~3 orders of magnitude lower. The citing authors' own observation of higher-mass electrophoretic components containing TIMP-3 and vitronectin is not something this paper reports. (LLM, conf=0.70)
- Partly supportedcites [23] Elgawish, A., Glomb, M., Friedlander, M. & Monnier, V. M. R. (1996) J. Biol. Chem. 271, 12964-12971. sourceExperimental — accuracy not yet measured
Our copy of Elgawish et al. (1996) supports the carbohydrate-oxidation half of the attributed point: the Introduction (p.1) notes that 'metal-catalyzed glucose autoxidation may be more important than glycation for generation of fluorescent protein adducts and cross-links' and that deoxyosones/glyoxal and 'reactive ketoaldehydes might be responsible for collagen cross-linking', and the Discussion proposes an H2O2- and Amadori-product-driven covalent lysine-lysine cross-link. The lipid-oxidation half is not asserted by this paper: in the Discussion it appears only as an alternative model ('H2O2 ... could catalyze collagen cross-linking, e.g. through lipid peroxidation (44)'), which the authors immediately discount for their system ('Lipid peroxidation, however, is unlikely to be involved since many studies have shown that it is not preventable by catalase'). The paper also reports no electrophoretic high-mass protein components (its cross-linking readouts are tendon breaking time, linked fluorescence, CML, pentosidine), so it does not address the TIMP-3/vitronectin observation itself. (LLM, conf=0.72)
hedgedstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen.”
- Also stated in: § Results · hedged
“Tissue metalloproteinase inhibitor 3 (TIMP3), clusterin, vitronectin and serum albumin appear to be common drusen proteins, detectable in up to 80% of the tissues from the 18 normal donors”
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins.”
- Also stated in: § Results · plain
“Western results (Fig. 3) revealed more frequent CEP immunoreactivity among the AMD samples than in the normal controls. Specifically, nine of the 11 AMD samples were immunopositive whereas only two of the 11 age-matched controls were CEP immunoreactive. Statistically these CEP immunoreactivity results are significantly different between AMD and normal donors (Fischer's test, P value = 0.004 single”
plainstates an associationn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunocytochemical studies have thus far localized ≈ 16% of these proteins in drusen.”
- Also stated in: § Discussion · plain
“To verify drusen localization, immunocytochemical studies are ongoing, and to date 21 of the identified proteins (16%) have been confirmed as drusen components in our laboratories and elsewhere.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
20 more claims
Create a free account to see all 39 claims and to verify the 14 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum albumin is one of the major proteins modified with CEP”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors.”
Reported 65 · recomputed 67.741935
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“About 38% (41 ∕ 107) of the proteins identified from normal donor drusen were also found in drusen from AMD donors”
§ Discussion
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Twenty-one of the 62 proteins detected in drusen from AMD tissue ( ≈ 33%) were not observed in normal donor drusen (Table 3).”
Reported 21 · recomputed 22
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Identification of the gene responsible for Best macular dystrophy
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., et al. (1998) · Nature Genetics · doi:10.1038/915 · Cited by 689
Positional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497
Research works printed but not linked: 3
- Midena E., Deglii Angeli, C., Blarzino, M., Valenti, M. & Segato, T. (1997) Invest. Ophthalmol. Visual Sci.38,469-477.9040480
- Kamei M. & Hollyfield, J. E. (1999) Invest. Ophthalmol. Visual Sci.40,2367-2375.10476804
- Handa, J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T. & Hjelmeland, L. M. (1999) Invest. Ophthalmol. Visual Sci. 40, 775-779.
Cited by
Items 401–500 of 1,000
Williams, B. L., Seager, N. A., Gardiner, J. D., Pappas, C. M., Cronin, M. C., Filippo, C. A. D. S., Anstadt, R. A., Liu, J., Toso, M., Nichols, L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103617118 · Cited by 64
“AMD is characterized by the accumulation of membranous debris and protein aggregates that include ECM proteins such as TIMP3 and vitronectin (40, 41) in the sub-RPE space.”
BackgroundMolecular Mechanisms of Retinal Pigment Epithelium Dysfunction in Age-Related Macular Degeneration
Kim, J., Lee, Y. J., & Won, J. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212298 · Cited by 64
“While the relationship between neovascular AMD and the impaired complement system is unknown, C3a, C5a, complement factor B, and MAC were shown to increase CNV lesions in a laser-induced CNV animal model by increasing the angiogenic factors secretion such as VEGF, TGF-β2, and β-FGF from the RPE [67,68].”
BackgroundIron, the retina and the lens: A focused review
García-Castiñeiras, S. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.03.003 · Cited by 57
“Carbonyl 4hydroxy-7-oxohept-5-enoic acid, a fragment derived from lipid peroxidation of DHAcontaining phospholipids, reacts with amino groups of proteins to produce 2-(ωcarboxyethyl)pyrrole adducts (CEP adducts) (Crabb et al., 2002).”
BackgroundInfluentialMorohoshi, K., Patel, N., Ohbayashi, M., Chong, V. N., Grossniklaus, H. E., Bird, A. C., & Ono, S. J. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.09.017 · Cited by 65
“The molecular and cellular constituents of drusen and ECM in the human Bruch's membrane have recently been analyzed, and several reports suggest that these molecules could be autoantigens contributing to the pathogenesis of AMD (Crabb et al., 2002; Mullins et al., 2000; Umeda et al., 2005).”
BackgroundSparrow, J. R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_5 · Cited by 66
Stem Cells as Tools in Regenerative Therapy for Retinal Degeneration
Enzmann, V., Yolcu, E., Kaplan, H. J., & Ildstad, S. T. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.65 · Cited by 65
“Additional reports support a role for the immune system, including complement activation, whereby accumulation of extracellular plaques and deposits elicits a local chronic inflammatory response that exacerbates the effects of primary pathogenic stimuli, in the development of drusen and the pathogenesis of AMD.8-10 Ar…”
BackgroundInfluentialSorsby fundus dystrophy—A review of pathology and disease mechanisms
Christensen, D. R. G., Brown, F. E., Cree, A. J., Ratnayaka, J. A., & Lotery, A. J. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.08.014 · Cited by 60
“Levels of TIMP3 in BrM have been seen to increase with age in healthy tissue (Kamei and Hollyfield, 1999).”
InfluentialDrugs in Phase II clinical trials for the treatment of age-related macular degeneration
Tolentino, M. J., Dennrick, A., John, E., & Tolentino, M. S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.961601 · Cited by 58
“CFH can be loosely categorized as an anti-inflammatory [19,20].”
BackgroundComplement dysregulation in AMD: RPE-Bruch’s membrane-choroid
Sparrow, J. R., Ueda, K., & Zhou, J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.007 · Cited by 57
“These protein modifications are generated by fragments released following the oxidation of docosahexaenoate-containing lipids in photoreceptor cells (Crabb et al., 2002).”
BackgroundNewsome, D. A. (2008) · Current Eye Research · doi:10.1080/02713680802178437 · Cited by 66
Monomeric C‐reactive protein and inflammation in age‐related macular degeneration
Chirco, K. R., Whitmore, S. S., Wang, K., Potempa, L. A., Halder, J. A., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2016) · The Journal of Pathology · doi:10.1002/path.4766 · Cited by 58
Zhang, Y., Cross, S. D., Stanton, J. B., Marmorstein, A. D., Le, Y. Z., & Marmorstein, L. Y. (2017) · PubMed Central · Cited by 68
Shang, F., & Taylor, A. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.001 · Cited by 65
“Glycated proteins and advanced glycation end products (AGE) accumulate at accelerating rates upon aging in the retina, specifically in drusen [13, 14, 18], as well as in the aging lens [16], and the process is accelerated under diabetic conditions [13, 136].”
BackgroundTubby-like Protein 1 (TULP1) Interacts with F-actin in Photoreceptor Cells
Xi, Q., Pauer, G. J. T., Marmorstein, A. D., Crabb, J. W., & Hagstrom, S. A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0693 · Cited by 60
Self-citationTong, Y., Ami, T. B., Hong, S., Heintzmann, R., Gerig, G., Ablonczy, Z., Curcio, C. A., Ach, T., & Smith, R. T. (2016) · Retina · doi:10.1097/iae.0000000000001325 · Cited by 60
Zarbin, M. A. (2003) · Europe PMC (PubMed Central) · Cited by 68
Protein Database, Human Retinal Pigment Epithelium
West, K. A., Yan, L., Shadrach, K. G., Jian, S., Hasan, A., Miyagi, M., Crabb, J. S., Hollyfield, J. G., Marmorstein, A. D., & Crabb, J. W. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.d200001-mcp200 · Cited by 59
“To facilitate studies of retina and RPE in health and disease (4), we have initiated the development of a human RPE protein database.”
BackgroundSelf-citationChirco, K. R., & Potempa, L. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00539 · Cited by 58
Oxidative stress in dry age-related macular degeneration and exfoliation syndrome
Chiras, D., Kitsos, G., Petersen, M. B., Skalidakis, I., & Κroupis, C. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.968703 · Cited by 62
Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5
Shu, X., Tulloch, B., Lennon, A., Vlachantoni, D., Zhou, X., Hayward, C., & Wright, A. F. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl091 · Cited by 59
Fernandez-Godino, R., & Pierce, E. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-28143-0 · Cited by 58
Not All Stressors Are Equal: Mechanism of Stressors on RPE Cell Degeneration
Tong, Y., & Wang, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.591067 · Cited by 60
Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch's membrane
Murdaugh, L. S., Wang, Z., Priore, L. V. D., Dillon, J. P., & Gaillard, E. R. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.01.014 · Cited by 60
Proteomics of vitreous in neovascular age-related macular degeneration
Nobl, M., Reich, M., Dacheva, I., Siwy, J., Mullen, W., Schanstra, J. P., Choi, C. Y., Kopitz, J., Kretz, F. T. A., Auffarth, G. U., et al. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.01.001 · Cited by 61
The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease
Schori, C., Trachsel, C., Grossmann, J., Zygoula, I., Barthelmes, D., & Grimm, C. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24122 · Cited by 63
Proteomic Characterization of Isolated Retinal Pigment Epithelium Microvilli
Bonilha, V. L., Bhattacharya, S. K., West, K. A., Sun, J., Crabb, J. W., Rayborn, M. E., & Hollyfield, J. G. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400106-mcp200 · Cited by 56
“Protein identifications from MS/MS data utilized the Swiss-Prot, and the NCBI sequence databases and the search engines Protein Lynx TM Global server and Mascot (Matrix Science, London, United Kingdom) (5, 13, 14).”
MethodSelf-citationA systems biology approach uncovers novel disease mechanisms in age-related macular degeneration
Orozco, L. D., Owen, L. A., Hofmann, J. W., Stockwell, A., Tao, J., Haller, S., Mukundan, V. T., Clarke, C., Lund, J. M., Sridhar, A., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100302 · Cited by 58
“CRYAB is a widely expressed small heat shock protein enriched in AMD soft drusen.(60) Inmousemodels of retinal neovascularization, the absence of CRYAB reduced VEGFA protein levels and vascular phenotypes.”
BackgroundProteomic Landscape of the Human Choroid–Retinal Pigment Epithelial Complex
Skeie, J. M., & Mahajan, V. B. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2065 · Cited by 56
Eyeballing cholesterol efflux and macrophage function in disease pathogenesis
Sene, A., & Apte, R. S. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.007 · Cited by 56
Age‐Related Macular Degeneration: Linking Clinical Presentation to Pathology
Nivison‐Smith, L., Milston, R., Madigan, M. C., & Kalloniatis, M. (2014) · Optometry and Vision Science · doi:10.1097/opx.0000000000000281 · Cited by 61
“Drusen are also associated with immune cells and proteins in the complement cascade, highlighting the role of inflammation in drusen progression and AMD pathogenesis.(38,39,41) Although the exact process of drusen formation is not known, Curcio and coworkers recently suggested a model that mirrors plaque formation in…”
BackgroundComplement regulation in the eye: implications for age-related macular degeneration
Wilke, G. A., & Apte, R. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178296 · Cited by 55
“Drusen are aggregates of proteins, lipids, and cellular debris; major components include albumin, apolipoprotein E, complement factors, and immunoglobulin (42–44).”
Nan, R., Gor, J., Lengyel, I., & Perkins, S. J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.030 · Cited by 64
Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration
Mulfaul, K., Ozaki, E., Fernando, N., Brennan, K., Chirco, K. R., Connolly, E., Greene, C., Maminishkis, A., Salomon, R. G., Linetsky, M. D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.064 · Cited by 59
“Of note, CEPadducted proteins and CEP-ethanolamine phospholipids (CEP-EPs) are found in abundance in eyes and serum of patients with AMD compared with age-matched controls (Wang et al., 2014; Crabb et al., 2002; Gu et al., 2003) and are conceivably inducing activation of TLR2 in AMD and in other retinal diseases where…”
BackgroundSelf-citationMatrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
García‐Onrubia, L., Valentín-Bravo, F. J., Coco, R. M., González‐Sarmiento, R., Jimeno, J. C. P., Usategui‐Martín, R., & Pastor‐Idoate, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165934 · Cited by 61
Hu, M. L., Quinn, J., & Xue, K. (2021) · Life · doi:10.3390/life11070635 · Cited by 56
“Over 129 different proteins have been identified in drusen [11], including apolipoproteins (E, B, A and C), amyloid-beta (Aβ), complement factors (C3, C5, C8, C9), complement factor H and vitronectin [10,12].”
BackgroundGlutathione and Lipid Peroxide Changes in Pseudoexfoliation Syndrome
Gartaganis, S. P., Georgakopoulos, C. D., Patsoukis, N., Gotsis, S., Gartaganis, V. S., & Georgiou, C. D. (2005) · Current Eye Research · doi:10.1080/02713680590968367 · Cited by 55
Lin, J. B., Moolani, H. V., Sene, A., Sidhu, R., Kell, P., Lin, J. B., Dong, Z., Ban, N., Ory, D. S., & Apte, R. S. (2018) · JCI Insight · doi:10.1172/jci.insight.120157 · Cited by 54
Garland, D. L., Fernandez-Godino, R., Kaur, I., Speicher, K. D., Harnly, J. M., Lambris, J. D., Speicher, D. W., & Pierce, E. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt395 · Cited by 53
Models of retinal diseases and their applicability in drug discovery
Malek, G., Busik, J. V., Grant, M. B., & Choudhary, M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1430136 · Cited by 55
“These deposits express biomarkers of drusen including: vitronectin, carboxymethyl lysine, and tissue inhibitor metalloproteinase 3 [209,210].”
BackgroundTear film proteome in age-related macular degeneration
Winiarczyk, M., Kaarniranta, K., Winiarczyk, S., Adaszek, Ł., Winiarczyk, D., & Mackiewicz, J. (2018) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-018-3984-y · Cited by 54
“Post-mortem retinal samples show differences between protein distribution between central and peripheral retina in AMD [27], also drusen proteomic composition seems to be different in healthy individuals and AMD patients [40].”
BackgroundGurubaran, I. S., Viiri, J., Koskela, A. K. J., Hyttinen, J. M. T., Paterno, J. J., Kis, G. N., Antal, M., Urtti, A. O., Kauppinen, A., Felszeghy, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061976 · Cited by 56
Wu, K. H. C., Tan, A. G., Rochtchina, E., Favaloro, E. J., Williams, A., Mitchell, P., & Wang, J. J. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0223 · Cited by 57
Pyroptosis: A New Insight Into Eye Disease Therapy
Zhang, Y., Jiao, Y., Li, X., Gao, S., Zhou, N., Duan, J., & Zhang, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797110 · Cited by 55
“, organelles, melanin granules, lipofuscin, amyloid-β (Aβ), apolipoprotein E, and oxidation byproducts, as well as numerous inflammation-related factors, such as complement components, immunoglobulins, HLA molecules, and acute phase proteins (Hageman et al., 1999; Hageman and Mullins, 1999; Crabb et al., 2002; Sakaguc…”
BackgroundBorchert, G. A., Shamsnajafabadi, H., Hu, M. L., Silva, S. R. D., Downes, S. M., MacLaren, R. E., Xue, K., & Cehajic‐Kapetanovic, J. (2023) · Cells · doi:10.3390/cells12162092 · Cited by 54
“A proteomic analysis of drusen from AMD donor eyes and controls identified multiple proteins altered by oxidation, including vitronectin, carboxymethyl lysine and tissue metalloproteinase inhibitor 3 [44].”
BackgroundClusterin in neurological disorders: Molecular perspectives and clinical relevance
Charnay, Y., Imhof, A., Vallet, P. G., Kovari, E., Bouras, C., & Giannakopoulos, P. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.05.006 · Cited by 53
Sreekumar, P. G., Li, Z., Wang, W., Spee, C. K., Hinton, D. R., Kannan, R., & MacKay, J. A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.014 · Cited by 53
“Proteomic analysis showed αB crystallin to be a major protein constituent of AMD-associated drusen, which are subretinal protein and lipid-rich extracellular deposits [46], pointing to the significance of this protein in AMD etiology.”
Xi, Q., Pauer, G. J. T., Ball, S. L., Rayborn, M., Hollyfield, J. G., Peachey, N. S., Crabb, J. W., & Hagstrom, S. A. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0059 · Cited by 52
Self-citationROLE OF GENETIC FACTORS AND INFLAMMATION IN AGE-RELATED MACULAR DEGENERATION
MOSHFEGHI, D. M., & BLUMENKRANZ, M. S. (2007) · Retina · doi:10.1097/iae.0b013e31802e3e9b · Cited by 52
New therapeutic targets in atrophic age-related macular degeneration
Petrukhin, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.625 · Cited by 55
“There are multiple lines of evidence supporting the critical role of inflammation in etiology of atrophic AMD [60-68].”
BackgroundInfluentialSorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells†
Langton, K. P., McKie, N., Smith, B. M., Brown, N. J., & Barker, M. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi385 · Cited by 57
Salomon, R. G., Hong, L., & Hollyfield, J. G. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200206v · Cited by 59
Self-citationEmerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration
Malek, G., & Lad, E. M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1709-x · Cited by 55
“These include amyloid-beta (b), complement factors, amyloid P component, and carboxyethyl pyrrole adducts generated by lipid oxidation [87, 90].”
BackgroundCarver, K. A., & Yang, D. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17117 · Cited by 55
“debris, drusen-like deposits, and drusen build up on apical and basolateral sides of the RPE monolayer, and drusen are composed of materials found in RPE cells.(5,15,28,69) The strong”
BackgroundInflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis
Xiong, L., McCoy, M. G., Komuro, H., West, X. Z., Yakubenko, V. P., Gao, D., Dudiki, T., Milo, A., Chen, J. M., Podrez, E. A., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.031 · Cited by 55
Wang, H., Wittchen, E. S., Jiang, Y., Ambati, B. K., Grossniklaus, H. E., & Hartnett, M. E. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8230 · Cited by 52
Significance of Advanced Glycation End Products in Aging-Related Disease
Nagai, R., Mori, T., Yamamoto, Y., Kaji, Y., & Yonei, Y. (2010) · Anti-aging Medicine · doi:10.3793/jaam.7.112 · Cited by 58
Seo, S.-J., Krebs, M. P., Mao, H., Jones, K., Conners, M., & Lewin, A. S. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.05.013 · Cited by 51
“Oxidative stress in the retinal pigment epithelium (RPE) is hypothesized to be a major contributor to the development of agerelated macular degeneration (AMD) (Beatty et al., 2000; Cai et al., 2000; Crabb et al., 2002; Shen et al., 2007; Totan et al., 2009).”
Innate Immune Network in the Retina Activated by Optic Nerve Crush
Templeton, J. P., Freeman-Anderson, N. E., Nickerson, J. M., Jablonski, M. M., Rex, T. S., Williams, R. W., & Geisert, E. E. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11175 · Cited by 53
“For example, members of the complement cascade are associated with the pathological changes occurring in Alzheimer disease8–11 and spinal cord injury.12,13 Within the past decade, the significance of the complement system was dramatically demonstrated by its role in AMD, where recent studies have shown that common var…”
BackgroundInfluentialMacrophages eyed in macular degeneration
Forrester, J. V. (2003) · Nature Medicine · doi:10.1038/nm1103-1350 · Cited by 61
Identification of Human Plasma Proteins as Major Clients for the Extracellular Chaperone Clusterin
Wyatt, A. R., & Wilson, M. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079566 · Cited by 55
Prevention of the Onset of Age-Related Macular Degeneration
Carlo, E. D., & Augustin, A. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153297 · Cited by 52
“The formation of drusen is mainly influenced by oxidative protein modifications, as shown by previous studies [34].”
ResultMichalska‐Małecka, K., Kabiesz, A. M., Nowak, M., & Śpiewak, D. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.09.007 · Cited by 59
Dasch, B. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1501 · Cited by 51
“In addition, immunohistochemical analyses have shown that drusen contain different immune reactants, including complement, immunoglobulins, and acute-phase proteins.(7-9,37-39) A possible trigger of inflammation may be an injured retinal pigment epithelium, caused by hypoxia, oxidative insults, lipofuscin accumulation…”
BackgroundEdwards, G., Olson, C. G., Euritt, C. P., & Koulen, P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.890021 · Cited by 54
Proteomic analysis of the aqueous humor in patients with wet age‐related macular degeneration
Yao, J., Liu, X., Yang, Q., Zhuang, M., Wang, F., Chen, X., Hang, H., Zhang, W., & Liu, Q. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200012 · Cited by 51
Metallothioneins (MTs) in the human eye: a perspective article on the zinc–MT redox cycle
González‐Iglesias, H., Álvarez, L., García, M., Petrash, C., Sanz‐Medel, A., & Coca‐Prados, M. (2013) · Metallomics · doi:10.1039/c3mt00298e · Cited by 52
A potential role for β‐ and γ‐crystallins in the vascular remodeling of the eye
Zhang, C., Gehlbach, P. L., Gongora, C., Cano, M., Fariss, R. N., Hose, S., Nath, A., Green, W. R., Goldberg, M. F., Zigler, J. S., et al. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20494 · Cited by 50
“Although highly specialized for lens, the crystallins are also expressed in other tissues (Srinivasan et al., 1992; Deretic et al., 1994; Head et al., 1995; Sinha et al., 1998; Magabo et al., 2000; Jones et al., 1999; Crabb et al., 2002; Xi et al., 2003).”
BackgroundRisk Factors for Age-Related Maculopathy
Connell, P., Keane, P. A., O’Neill, E. C., Al‐Taie, R., Loane, E., Neelam, K., Nolan, J. M., & Beatty, S. (2009) · Journal of Ophthalmology · doi:10.1155/2009/360764 · Cited by 57
“The human immune system contains both innate and adaptive components [102].”
BackgroundInfluentialGugiu, B. G., Mesaros, C., Sun, M., Gu, X., Crabb, J. W., & Salomon, R. G. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050247f · Cited by 50
Self-citationDifferential Proteomic Analysis of the Mouse Retina
Cavusoglu, N., Thiersé, D., Mohand‐Saïd, S., Chalmel, F., Poch, O., DORSSELAER, A. V., Sahel, J., & Léveillard, T. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300029-mcp200 · Cited by 53
Oxidation as “The Stress of Life”
Malinin, N. L., West, X. Z., & Byzova, T. V. (2011) · Aging · doi:10.18632/aging.100385 · Cited by 47
“CAPs were originally isolated from retinas of patients with advanced agerelated macular degeneration (AMD) [23], and later were also found in other organs with substantial oxidative stress [22].”
BackgroundInfluentialAnalysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration
Rinsky, B., Beykin, G., Grunin, M. A., Amer, R., Khateb, S., Tiosano, L., Almeida, D., Hagbi-Levi, S., Elbaz-Hayoun, S., & Chowers, I. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.10.18 · Cited by 51
Fletcher, E. L. (2020) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12671 · Cited by 54
“5 The importance of innate immunity in the development of AMD is exemplified by the accumulation of complement components within drusen deposits 6,7 and also the widespread inheritance of mutations in genes affecting the complement system including single nucleotide polymorphisms in Complement…”
A Review of the Role of the Intestinal Microbiota in Age-Related Macular Degeneration
Lin, P., McClintic, S. M., Nadeem, U., & Skondra, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102072 · Cited by 55
Diseases of protein aggregation and the hunt for potential pharmacological agents
Wang, S. S. ‐., Wu, J. W., Yamamoto, S., & Liu, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700065 · Cited by 49
Landowski, M., & Rickman, C. B. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0067 · Cited by 48
Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
Tang, S., Yang, J., Xiao, B., Wang, Y., Lei, Y., Lai, D., & Qiu, Q. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.12.20 · Cited by 49
“116 These extracellu-Lipid lar deposits, including BLinD, drusen, and SDD, encompass significant amounts of apolipoproteins (E, B, A-I, C-I, and C-II)-rich lipoproteins, alongside complement components that play a significant role in the progression of AMD, as previously discussed.”
BackgroundIn Vivo Quantification of Retinal Changes Associated With Drusen in Age-Related Macular Degeneration
Rogala, J., Zangerl, B., Assaad, N. N., Fletcher, E. L., Kalloniatis, M., & Nivison‐Smith, L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16221 · Cited by 49
Glyoxalase System as a Therapeutic Target against Diabetic Retinopathy
Aragonès, G., Rowan, S., Francisco, S. G., Yang, W., Weinberg, J., Taylor, A., & Bejarano, E. (2020) · Antioxidants · doi:10.3390/antiox9111062 · Cited by 50
“using mass spectrometry, observed several oxidized proteins in drusen, extracellular deposits accumulated below the RPE on Bruch’s membrane, from human AMD samples [25].”
Turowski, P., Adamson, P., Sathia, J., Zhang, J. J., Moss, S. E., Aylward, G. W., Hayes, M. J., Kanuga, N., & Greenwood, J. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0943 · Cited by 47
Cherepanoff, S., Mitchell, P., Wang, J. J., & Gillies, M. C. (2006) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01281.x · Cited by 47
“Proteomic techniques have been successfully used to identify abnormal proteins present in AMD retinae.(37) The multiple antigens targeted by autoantibodies from AMD serum can be similarly characterized.”
MethodHu, H., Liu, Y., Wang, L., & Li, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173716 · Cited by 48
Askou, A. L., Alsing, S., Holmgaard, A., Bek, T., & Corydon, T. J. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13407 · Cited by 49
“…oxidative stress (Age-Related Eye Disease Study Research 2001; Gu et al. 2003; Zarbin 2004), inflammation (Mullins et al. 2000; Hageman et al. 2001; Crabb et al. 2002; Fritsche et al. 2013) and pathological angiogenesis (Aiello et al. 1994; Kvanta et al. 1996; Lopez et al. 1996; Haines et al.…”
BackgroundSuppression of Light-Induced Oxidative Stress in the Retina by Mitochondria-Targeted Antioxidant
Baksheeva, V. E., Tiulina, V. V., Tikhomirova, N. K., Gancharova, O. S., Komarov, S. V., Philippov, P. P., Zamyatnin, A. A., Senin, I. I., & Zernii, E. Y. (2018) · Antioxidants · doi:10.3390/antiox8010003 · Cited by 49
“Furthermore, they possess modifications by carboxyethyl pyrrole, induced by oxidation of docosahexaenoic acid, which originates mainly from photoreceptor membranes [49,50].”
BackgroundBisretinoid phospholipid and vitamin A aldehyde: shining a light
Kim, H. J., & Sparrow, J. R. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000742 · Cited by 47
“Given that photooxidation of A2E and all-trans-retinal dimer has also been shown to incite complement activation (82, 83) together with evidence that these carbonyl-modified proteins are present in deposits (drusen) that accumulate on the basal side of RPE cells in vivo (84, 85), the photodegradation of bisretinoids i…”
BackgroundJiang, H., Shi, X., Fan, Y., Wang, D., Li, B., Zhou, J., Pei, C., & Ma, L. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.10.005 · Cited by 48
Biswal, M. R., Ahmed, C. M. I., Ildefonso, C. J., Han, P., Li, H., Jivanji, H., Mao, H., & Lewin, A. S. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.022 · Cited by 47
Hoppe, G., O'NEIL, J. A., Hoff, H. F., & Sears, J. E. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.01.004 · Cited by 47
C9-R95X Polymorphism in Patients with Neovascular Age-Related Macular Degeneration
Nishiguchi, K. M., Yasuma, T. R., Tomida, D., Nakamura, M., Ishikawa, K., Kikuchi, M., Ohmi, Y., Niwa, T., Hamajima, N., Furukawa, K., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8425 · Cited by 51
Wang, H., Fotheringham, L., Wittchen, E. S., & Hartnett, M. E. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.08.017 · Cited by 47
Silva, A. S., Teixeira, A., Bavia, L., Lin, F. L. H., Velletri, R., Belfort, R., & Isaac, L. (2012) · PubMed Central · Cited by 58
The Diverse Roles of TIMP-3: Insights into Degenerative Diseases of the Senescent Retina and Brain
Dewing, J. M., Carare, R. O., Lotery, A. J., & Ratnayaka, J. A. (2019) · Cells · doi:10.3390/cells9010039 · Cited by 60
“Similarly, 65% of drusen proteins were found in drusen from both AMD and healthy patients, with only 33% being exclusive to diseased (AMD) eyes [47].”
BackgroundSorsby fundus dystrophy:Insights from the past and looking to the future
Anand‐Apte, B., Chao, J. R., Singh, R., & Stöhr, H. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24317 · Cited by 45
Age-Related Macular Degeneration: Cellular and Molecular Signaling Mechanisms
Jiang, F., Ma, J., Lei, C., Zhang, Y., & Zhang, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136174 · Cited by 49
“Proteomic analyses identify drusen as extracellular deposits rich in lipids, complement proteins (e.g., C3, C5b-9), and inflammatory mediators such as amyloid-β (A β ) [24], with lipids constituting more than 40% of the drusen volume [25].”
DJ-1-Dependent Regulation of Oxidative Stress in the Retinal Pigment Epithelium (RPE)
Shadrach, K. G., Rayborn, M. E., Hollyfield, J. G., & Bonilha, V. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067983 · Cited by 46
“Previously, we [93,94] and other groups [95,96,97,98] reported that many of proteins found in drusen are normally found intracellularly in the RPE.”
BackgroundSelf-citationChuang, J.-Z., Yang, N., Nakajima, N., Otsu, W., Fu, C., Yang, H. H., Lee, M. P., Akbar, A. F., Badea, T. C., Guo, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27935-9 · Cited by 49
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44
“Of over 100 proteins identified in drusen, the commonest include vitronectin and clusterin (which both participate in the control of the lytic activity of complement), with TIMP-3, serum albumin, and crystallins [67] also identified—several of which have undergone oxidative protein modifications [68].”
BackgroundLibby, R. T., & Gould, D. B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_46 · Cited by 47
“N IH -PA Author M anuscript N IH -PA Author M anuscript (Crabb et al. 2002; Hageman et al. 2001).”
BackgroundFlinn, J. M., Kakalec, P. A., Tappero, R. V., Jones, B. F., & Lengyel, I. (2014) · Metallomics · doi:10.1039/c4mt00058g · Cited by 46
Age- and Light-Dependent Development of Localised Retinal Atrophy in CCL2−/−CX3CR1GFP/GFP Mice
Chen, M., Hombrebueno, J. R., Luo, C., Penalva, R., Zhao, J., Colhoun, L., Pandi, S. P. S., Forrester, J. V., & Xu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061381 · Cited by 42
Metadata
- Authors
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 23
- Pages
- 14682-14687
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137479
- OpenAlex
- W2136501493
- Semantic Scholar
- 56777252bd03c9f9e59663891e03c8a458996b5f
- Cited by
- 1,208
- References
- 39
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 35 · 2023: 39 · 2022: 52 · 2021: 56 · 2020: 49 · 2019: 34 · 2018: 65 · 2017: 62 · 2016: 44 · 2015: 56 · 2014: 73 · 2013: 57 · 2012: 69
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation Fighting Blindness
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health (5r01ey002362-23, EY06603)
- National Eye Institute (R56EY014240, EY014239, EY06603, EY 014240, F32EY006603, R01EY006603, R01EY014239, EY 02362, R01EY014240)
- National Institute of General Medical Sciences (R01GM021249, GM 21249)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- drusen, age-related macular degeneration, Bruch's membrane, retinal pigment epithelium, protein oxidation, carboxymethyllysine, vitronectin, clusterin, serum albumin, crystallins, drusen formation, AMD pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Aging, Choroid, Enzymes, Eye, Eye Proteins, Humans, Macular Degeneration, Middle Aged, Reference Values, Retina, Optic Disk Drusen, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.